Sections

WG on Biologicals

The EAACI Interest Group on Biologicals Task Force recently has published a review paper on biological drugs that are currently available or tested for the use in various allergic and urticarial pathologies. It provides an up-to-date overview on their state of development, area of use, adverse events, and future research directions.


·         State-of-the-art review on the use of biologicals in allergic disorders, which can be accessed HERE, in "Allergy".

·         Review of the adverse reactions to biologicals and their medical management, which can be accessed here.

·         Additionally, you can find updated information about adverse reactions to biological in the selected articles below:

  1. Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions



Last updated 24 October 2016
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel